{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:33:14Z","timestamp":1794105194131,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpainsymman.2026.04.623","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:23:48Z","timestamp":1778084628000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Olanzapine Prophylaxis for Opioid-Induced Nausea and Vomiting: A Single-Arm Exploratory Study"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-2849","authenticated-orcid":false,"given":"Eriko","family":"Satomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4354-3497","authenticated-orcid":false,"given":"Naho","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-9369","authenticated-orcid":false,"given":"Rumi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-0273","authenticated-orcid":false,"given":"Akiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-2293","authenticated-orcid":false,"given":"Naruaki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3844-2512","authenticated-orcid":false,"given":"Sayaka","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-2161","authenticated-orcid":false,"given":"Hiroto","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-6389","authenticated-orcid":false,"given":"Koji","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8896-2572","authenticated-orcid":false,"given":"Keisuke","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1781-2983","authenticated-orcid":false,"given":"Kota","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0864-0371","authenticated-orcid":false,"given":"Shota","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8130-6815","authenticated-orcid":false,"given":"Shunsuke","family":"Oyamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-3131","authenticated-orcid":false,"given":"Akio","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011056","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","volume":"29","author":"Wiffen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1634\/theoncologist.2017-0225","article-title":"Efficacy of prophylactic treatment for oxycodone-induced nausea and vomiting among patients with cancer pain (POINT): a randomized, placebo-controlled, double-blind trial","volume":"23","author":"Tsukuura","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0003","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0269216311404273","article-title":"Management of opioid-induced nausea and vomiting in cancer patients. Systematic review and evidence-based recommendations","volume":"25","author":"Laugsand","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0004","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0140-6736(92)90546-F","article-title":"Cancer pain: management","volume":"25","author":"Hanks","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-200363010-00002","article-title":"Responsible prescribing of opioids for the management of chronic pain","volume":"63","author":"Nicholson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3959(93)90165-L","article-title":"Patient-related barriers to management of cancer pain","volume":"52","author":"Ward","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","article-title":"Opioid induced nausea and vomiting","volume":"722","author":"Smith","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpainsymman.2024.10.033","article-title":"Genomic study in opioid-treated cancer patients identifies variants associated with nausea-vomiting","volume":"69","author":"Minnai","year":"2025","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0009","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.3390\/ijms25168845","article-title":"TMEM132Crs7296262 Single-nucleotide polymorphism is significantly associated with nausea induced by opioids administered for cancer pain and postoperative pain","volume":"25","author":"Kang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027565","article-title":"Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: a STROBE-compliant observational study","volume":"100","author":"Tanaka","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0011","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/jpm.2015.0203","article-title":"Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a questionnaire survey among Japanese physicians","volume":"18","author":"Tsukuura","year":"2015","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0012","first-page":"3531","article-title":"Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians\u2019 practice","volume":"27","author":"Giusti","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0013","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0014","unstructured":"NCCN Clinical Practice Guideline in Oncology. Adult cancer pain. 2025. Available: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1413. Accessed July 20, 2025."},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0015","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1200\/JCO.24.00381","article-title":"Naldemedine for opioid-induced constipation in patients with cancer: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"10","author":"Hamano","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(00)00037-6","article-title":"Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium","volume":"390","author":"Bymaster","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0019","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","author":"Navari","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1470-2045(19)30678-3","article-title":"Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Hashimoto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0021","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2020.1052","article-title":"Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial","volume":"6","author":"Navari","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0022","first-page":"s22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0023","first-page":"442","article-title":"Olanzapine","volume":"58","author":"Hale","year":"1997","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0024","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0033-3182(99)71210-7","article-title":"New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment","volume":"40","author":"Goldstein","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0025","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0026","first-page":"265","article-title":"Nausea in advanced cancer: relationships between intensity, burden, and the need for help","volume":"27","author":"Harder","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0027","first-page":"3341","article-title":"Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience","volume":"23","author":"Hernandez Torres","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0028","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-015-3669-8","article-title":"Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting","volume":"155","author":"Ng","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0029","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15360288.2019.1668902","article-title":"Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden","volume":"33","author":"Oderda","year":"2019","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15360288.2020.1829250","article-title":"Predictive factors of opioid-induced nausea in cancer patients","volume":"35","author":"Ogawa","year":"2021","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2026.04.623_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(23)00628-9","volume":"25","author":"Bajpai","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600775X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600775X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:37:44Z","timestamp":1782891464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539242600775X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S088539242600775X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.04.623","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine Prophylaxis for Opioid-Induced Nausea and Vomiting: A Single-Arm Exploratory Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.04.623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}